Works matching IS 00070920 AND DT 2019 AND VI 120 AND IP 5
Results: 13
HAI-2 as a novel inhibitor of plasmin represses lung cancer cell invasion and metastasis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prognostic impact of CD8 and programmed death-ligand 1 expression in patients with resectable non-small cell lung cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A novel approach to modelling transcriptional heterogeneity identifies the oncogene candidate CBX2 in invasive breast carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Physical activity and subsequent risk of kidney, bladder and upper urinary tract cancer in the Japanese population: the Japan Public Health Centre-based Prospective Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effect of increased body mass index on risk of diagnosis or death from cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Differential effects, on oncogenic pathway signalling, by derivatives of the HNF4 α inhibitor BI6015.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Inhibition of SIRT1 deacetylase and p53 activation uncouples the anti-inflammatory and chemopreventive actions of NSAIDs.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article